Report of Foreign Issuer (6-k)

Date : 08/06/2019 @ 10:05AM
Source : Edgar (US Regulatory)
Stock : Acasti Pharma Inc (ACST)
Quote : 2.15  0.11 (5.39%) @ 9:33PM
After Hours
Last Trade
Last $ 2.15 ▼ -0.00 (-0.14%)

Report of Foreign Issuer (6-k)

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

 

For the month of: August 2019   Commission File Number: 001-35776

 

 

 

ACASTI PHARMA INC.

(Name of Registrant)

 

 

 

545 Promende du Centropolis
Suite 100
Laval, Québec
Canada H7T 0A3
(Address of Principal Executive Office )

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   x             Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   ¨

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 

Yes   ¨              No   x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

 

 

 

This Report on Form 6-K including the exhibits hereto shall be deemed to be incorporated by reference into Acasti Pharma Inc.’s registration statements on Form S-8 (File No. 333-191383), Form S-8 (File No. 333-227476), Form F-3 (File No. 333-223464) and Form F-3 (File No. 333-220755) and to be a part thereof from the date on which this report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished. 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    ACASTI PHARMA INC.  
       
Date: August 5, 2019 By: /s/ Jan D’Alvise  
    Name: Jan D’Alvise  
    Title: Chief Executive Officer  

 

 

 

 

 

 

 

 

EXHIBIT INDEX

   
Exhibit Description of Exhibit
   
99.1 Management Information Circular dated July 24, 2019
   
99.2 Form of Proxy
   
99.3 Form of Voting Instruction Form

 

 

 

 

 

 

 

 

Acasti Pharma (NASDAQ:ACST)
Historical Stock Chart

1 Year : From Nov 2018 to Nov 2019

Click Here for more Acasti Pharma Charts.

Acasti Pharma (NASDAQ:ACST)
Intraday Stock Chart

Today : Monday 18 November 2019

Click Here for more Acasti Pharma Charts.

Latest ACST Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.